Ds Healthcare Cmn (DSKX) 0.67 $DSKX DS Healthcare

New Post Public Reply Private Reply Replies (0) Message Board

Jul 10, 2016 at 6:15 PM

Ds Healthcare Cmn (DSKX) 0.67 $DSKX

DS Healthcare Receives Second Notice of Failure to Satisfy Continued Listing Rule
ACCESSWIRE - Fri Jun 10, 3:31PM CDT
POMPANO BEACH, FL / ACCESSWIRE / June 10, 2016 / DS Healthcare Group, Inc. (DSKX) (the "Company"

received a letter from Nasdaq dated June 7th, 2016 indicating that Nasdaq had not received the Company's Form 10-Q for the quarter ended March 31, 2016, in addition to remaining delinquent in filing its Form 10-K for the period ended December 31, 2015 (the "Initial Delinquent Filing"

. As a result, Nasdaq indicated that the Company does not comply with the Nasdaq Listing Rules (the "Rules"

for continued listing.
DSKX: 0.67 (-0.18)

DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of DS Healthcare Group, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 31, 2016 - DSKX
PR Newswire - Tue May 31, 11:05AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
DSKX: 0.67 (-0.18)

May 31 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against DS Healthcare Group, Inc.
BusinessWire - Fri May 27, 1:24PM CDT
Law Offices of Howard G. Smith reminds investors of the upcoming May 31, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class"

of investors who purchased DS Healthcare Group, Inc. ("DS Healthcare" or the "Company"

(NASDAQ: DSKX) securities between August 12, 2015 and March 28, 2016, inclusive (the "Class Period"

. DS Healthcare investors have until May 31, 2016 to file a lead plaintiff motion.
DSKX: 0.67 (-0.18)

INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving DS Healthcare Group, Inc. and a Lead Plaintiff Deadline of May 31, 2016 - DSKX
GlobeNewswire - Fri May 27, 11:35AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased DS Healthcare Group, Inc. (NASDAQ

SKX) securities between May 15, 2014 and April 3, 2016.
DSKX: 0.67 (-0.18)

DEADLINE APPROACHING: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against DS Healthcare Group, Inc. and Encourages Investors with Losses In Excess of $50,000 to Contact the Firm
ACCESSWIRE - Thu May 26, 7:13PM CDT
IRVINE, CA / ACCESSWIRE / May 26, 2016 / Khang & Khang LLP (the "Firm"

announces that a class action lawsuit has been filed against DS Healthcare Group, Inc. ("DS Healthcare Group" or the "Company"

(DSKX). Investors who purchased or otherwise acquired shares between May 15, 2014 and April 3, 2016, inclusive (the "Class Period"

, are encouraged to contact the Firm prior to the May 31, 2016, lead plaintiff motion deadline. If you purchased shares of DS Healthcare Group during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.
DSKX: 0.67 (-0.18)

May 31 Deadline Alert: GPM Reminds Investors of the Looming Deadline in the Class Action Lawsuit Against DS Healthcare Group, Inc.
BusinessWire - Thu May 26, 5:03PM CDT
Glancy Prongay & Murray LLP ("GPM"

reminds investors of the upcoming May 31, 2016 deadline to file a lead plaintiff motion in the class action filed by GPM on behalf of a class (the "Class"

of investors who purchased DS Healthcare Group, Inc. ("DS Healthcare" or the "Company"

(NASDAQ: DSKX) securities between May 15, 2014 and March 28, 2016, inclusive (the "Class Period"

.
DSKX: 0.67 (-0.18)

SHAREHOLDER UPDATE: Rosen Law Firm Reminds DS Healthcare Group, Inc. Investors of Important May 31 Deadline in Expanded Class Action
BusinessWire - Thu May 26, 9:50AM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of DS Healthcare Group, Inc. securities (NASDAQ: DSKX) from May 15, 2014 through April 3, 2016, inclusive (the "Class Period"

of the important May 31, 2016 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for DS Healthcare Group investors under the federal securities laws.
DSKX: 0.67 (-0.18)

MAY 31 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against DS Healthcare Group, Inc. and Reminds Investors with Losses In Excess of $50,000 to Contact the Firm
ACCESSWIRE - Wed May 25, 1:06PM CDT
LOS ANGELES, CA / ACCESSWIRE / May 25, 2016 / Lundin Law PC announces a class action lawsuit has been filed against DS Healthcare Group, Inc. ("DS Healthcare" or the "Company"

(NASDAQ: DSKX) concerning possible violations of federal securities laws between August 13, 2015 and March 23, 2015. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the May 31, 2016, lead plaintiff motion deadline.
DSKX: 0.67 (-0.18)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of DS Healthcare Group, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 31, 2016 - DSKX
GlobeNewswire - Wed May 25, 9:22AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
DSKX: 0.67 (-0.18)

FINAL NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against DS Healthcare Group, Inc. and Encourages Investors with Losses In Excess of $50,000 to Contact the Firm
ACCESSWIRE - Mon May 23, 10:53AM CDT
IRVINE, CA / ACCESSWIRE / May 23, 2016 / Khang & Khang LLP (the "Firm"

announces that a class action lawsuit has been filed against DS Healthcare Group, Inc. ("DS Healthcare Group" or the "Company"

(NASDAQ: DSKX). Investors who purchased or otherwise acquired shares between May 15, 2014 and April 3, 2016, inclusive (the "Class Period"

, are encouraged to contact the Firm prior to the May 31, 2016, lead plaintiff motion deadline.
DSKX: 0.67 (-0.18)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of DS Healthcare Group, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 31, 2016
BusinessWire - Fri May 20, 10:20AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
DSKX: 0.67 (-0.18)

DS Healthcare Update
ACCESSWIRE - Thu May 19, 10:26PM CDT
POMPANO BEACH, FL / ACCESSWIRE / May 19, 2016 / DS Healthcare Group, Inc. (NASDAQ: DSKX) (the "Company"

, is issuing this Press Release to provide certain updates.
DSKX: 0.67 (-0.18)

SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against DS Healthcare Group, Inc. and Reminds Investors With Losses in Excess of $100,000 to Contact the Firm
BusinessWire - Wed May 18, 4:41PM CDT
Lundin Law PC announces a class action lawsuit has been filed against DS Healthcare Group, Inc. ("DS Healthcare" or the "Company"

(Nasdaq: DSKX) concerning possible violations of federal securities laws between August 13, 2015 and March 23, 2015. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the May 31, 2016, lead plaintiff motion deadline.
DSKX: 0.67 (-0.18)

LEAD PLAINTIFF DEADLINE: Hagens Berman Reminds DS Healthcare Group, Inc. (NASDAQ: DSKX) Investors of the May 31, 2016 Deadline and the Expanded Class Period
GlobeNewswire - Wed May 18, 7:30AM CDT
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds DS Healthcare Group, Inc. (NASDAQ

SKX) investors of the May 31, 2016 lead plaintiff deadline in the securities class action lawsuit related to the Company's improper revenue recognition and other accounting improprieties and that the Class Period has been expanded to May 15, 2014 through April 3, 2016.
DSKX: 0.67 (-0.18)

EXPANDED CLASS PERIOD: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against DS Healthcare Group, Inc. And Encourages Investors With Losses In Excess of $50,000 To Contact The Firm
ACCESSWIRE - Mon May 16, 4:33PM CDT
IRVINE, CA / ACCESSWIRE / May 16, 2016 / Khang & Khang LLP (the "Firm"

announces that a class action lawsuit has been filed against DS Healthcare Group, Inc. ("DS Healthcare Group" or the "Company"

(Nasdaq: DSKX). Investors who purchased or otherwise acquired shares between May 15, 2014 and April 3, 2016, inclusive (the "Class Period"

, are encouraged to contact the Firm prior to the May 31, 2016, lead plaintiff motion deadline.
DSKX: 0.67 (-0.18)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving DS Healthcare Group, Inc. and a Lead Plaintiff Deadline of May 31, 2016
BusinessWire - Mon May 16, 1:13PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased DS Healthcare Group, Inc. (NASDAQ: DSKX) securities between May 15, 2014 and April 3, 2016.
DSKX: 0.67 (-0.18)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against DS Healthcare Group, Inc. (DSKX) and Lead Plaintiff Deadline: May 31, 2016
PR Newswire - Thu May 12, 9:00AM CDT
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, notifies investors of class action against DS Healthcare Group, Inc. ("DS Healthcare" or "the Company"

(NASDAQ: DSKX). The class action has been filed on behalf of a class consisting of all persons or entities who purchased DS Healthcare from August 13, 2015 through March 23, 2016, inclusive (the "Class Period"

.
DSKX: 0.67 (-0.18)

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against DS Healthcare Group, Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm
ACCESSWIRE - Tue May 10, 7:23PM CDT
LOS ANGELES, CA / ACCESSWIRE / May 10, 2016 / Lundin Law PC announces a class action lawsuit has been filed against DS Healthcare Group, Inc. ("DS Healthcare" or the "Company"

(Nasdaq: DSKX) concerning possible violations of federal securities laws between August 13, 2015 and March 23, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the May 31, 2016, lead plaintiff motion deadline.
DSKX: 0.67 (-0.18)

Lifshitz & Miller Law Firm Announces Investigation of DS Healthcare Group, Inc., Freshpet, Inc., Halyard Health Inc., La Quinta Holdings Inc., Ruby Tuesday, Inc., Silicon Graphics International Corp. and TerraForm Power, Inc.
PR Newswire - Fri May 06, 7:01PM CDT
DS Healthcare Group, Inc. (DSKX)
HYH: 34.47 (+1.10), RT: 3.64 (+0.10), TERP: 12.05 (+0.57), FRPT: 10.10 (+0.63), SGI: 5.19 (+0.15), LQ: 11.76 (+0.28), DSKX: 0.67 (-0.18)

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of DS Healthcare Group, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of May 31, 2016
BusinessWire - Mon May 02, 4:12PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
DSKX: 0.67 (-0.18)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Joshua Davenport: Celebrating 25 Years in Healthcare

25 Years Strong: Davenport's Journey in Healthcare Not every day you celebrate someone who's spent a quarter of a century in the trenches of healthcare. Joshua L. Davenport, RN, isn't just clocking years; he's built a legacy in emergency nursing and occupational health that speaks volumes about resilience and commitment to others. From Humble Beginnings to Health...

SLM Faces Legal Scrutiny as Losses Mount Amid Pause

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

DigitalXForce Booms with 514% Growth and Major Backing

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Chemours Faces Class Action Over Fraud Allegations

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

NEXT Properties Exchange Offers: The Full Breakdown

What's the Deal with These Exchange Offers? You know, nothing says 'we're changing things up' like an exchange offer. So what did NEXT Properties do? Well, they laid down two offers for the books on their outstanding 6.950% and 6.390% senior notes, due in 2044 and 2050, respectively. These are getting swapped out for some fresh 7.731% senior sustainability-linked notes...

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...